PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis. - Ross, Trenton; Kelly, Kenneth; Rinaldi, Anthony; Lech, Matthew; Martinez, Robert; Crowley, Collin; Gonzalez, Santos Carvajal; Boucher, Magalie; Shanthappa, Dinesh Hirenallur; Morin, Jeffrey; Opsahl, Alan C.; RVargas, Sarah; et al. (Journal of Hepatology, 2019)